Skip to content

Utility of EUS attenuation imaging for diagnosis and severity of steatohepatitis: a multicenter prospective study

EUS-AI for steatohepatitis - EUS-AI for steatohepatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060333
Enrollment
600
Registered
2026-01-14
Start date
2024-10-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

steatohepatitis

Interventions

None listed

Sponsors

Wakayama medical university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old 2. Patients scheduled for EUS and CT

Exclusion criteria

Exclusion criteria: 1. Cases in which EUS is difficult to perform 2. Patients who are judged to be ineligible for this study by the investigator 3. Patients with psychiatric disorders

Design outcomes

Primary

MeasureTime frame
The sensitivity, specificity, and accuracy with EUS-AI for steatohepatitis diagnosed by CT and the correlation between value with EUS-AI and CT value for liver.

Secondary

MeasureTime frame
1.The comparison of EUS-AI and conventional abdominal ultrasound AI for diagnosis according to steatohepatitis diagnosed by CT. 2.The comparison of EUS-AI and MRI for diagnosis according to steatohepatitis diagnosed by CT.

Countries

Japan

Contacts

Public ContactYasunobu Yamashita

Wakayama Medical University Second Department of Internal Medicine

yasunobu@wakayama-med.ac.jp0734472300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026